Prognostic Stage IIA Breast Cancer AJCC v8 Recruiting Phase 2 Trials for Oxaloacetic acid (DB16921)

IndicationStatusPhase
DBCOND0109633 (Prognostic Stage IIA Breast Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04290897Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer SurvivorsSupportive Care